Intranasal Therapeutics
Montvale
About Intranasal Therapeutics
Ikano Therapeutics a specialty pharmaceutical company, focuses on developing nasal spray drug products.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Total funding: $60.2M
- Funding stage: M&A
- Last round: Series B (Mar 2009)
- Website: intranasal.com
- Phone: (859)252-5080
Industries & Categories
Biotechnology, Medical, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/intranasal-therapeutics-2952572 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.